Free Trial

Motco Decreases Stock Holdings in The Cigna Group (NYSE:CI)

Motco trimmed its position in The Cigna Group (NYSE:CI - Free Report) by 14.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,284 shares of the health services provider's stock after selling 3,064 shares during the period. Motco's holdings in The Cigna Group were worth $5,475,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also modified their holdings of CI. Relyea Zuckerberg Hanson LLC boosted its position in The Cigna Group by 3.2% in the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider's stock worth $333,000 after purchasing an additional 35 shares in the last quarter. Legacy Financial Advisors Inc. raised its position in The Cigna Group by 3.1% during the fourth quarter. Legacy Financial Advisors Inc. now owns 1,250 shares of the health services provider's stock worth $374,000 after acquiring an additional 37 shares during the period. Sequoia Financial Advisors LLC lifted its holdings in The Cigna Group by 1.4% during the third quarter. Sequoia Financial Advisors LLC now owns 2,822 shares of the health services provider's stock valued at $807,000 after purchasing an additional 39 shares in the last quarter. Breakwater Capital Group grew its position in shares of The Cigna Group by 3.5% in the fourth quarter. Breakwater Capital Group now owns 1,144 shares of the health services provider's stock valued at $349,000 after purchasing an additional 39 shares during the period. Finally, Detalus Advisors LLC increased its stake in shares of The Cigna Group by 6.0% during the fourth quarter. Detalus Advisors LLC now owns 742 shares of the health services provider's stock worth $222,000 after purchasing an additional 42 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Analyst Ratings Changes


CI has been the subject of several research reports. Barclays started coverage on The Cigna Group in a research note on Wednesday, March 6th. They set an "overweight" rating and a $393.00 price objective for the company. Mizuho raised their price objective on The Cigna Group from $360.00 to $370.00 and gave the company a "buy" rating in a report on Monday, February 5th. Cantor Fitzgerald increased their target price on shares of The Cigna Group from $384.00 to $400.00 and gave the company an "overweight" rating in a research report on Friday, May 3rd. Oppenheimer boosted their price target on shares of The Cigna Group from $370.00 to $400.00 and gave the stock an "outperform" rating in a research report on Friday, May 3rd. Finally, Wells Fargo & Company upped their price objective on shares of The Cigna Group from $334.00 to $348.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 6th. Two equities research analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $366.14.

Check Out Our Latest Analysis on The Cigna Group

Insider Buying and Selling

In other The Cigna Group news, CEO David Cordani sold 2,000 shares of the company's stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $345.04, for a total transaction of $690,080.00. Following the completion of the sale, the chief executive officer now directly owns 336,783 shares of the company's stock, valued at approximately $116,203,606.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other The Cigna Group news, CEO David Cordani sold 2,000 shares of the business's stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $345.04, for a total value of $690,080.00. Following the transaction, the chief executive officer now directly owns 336,783 shares of the company's stock, valued at approximately $116,203,606.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the firm's stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $348.71, for a total transaction of $2,073,429.66. Following the completion of the sale, the senior vice president now owns 2,595 shares of the company's stock, valued at approximately $904,902.45. The disclosure for this sale can be found here. Insiders sold a total of 78,685 shares of company stock worth $27,622,407 in the last 90 days. Company insiders own 0.60% of the company's stock.

The Cigna Group Stock Down 0.2 %

NYSE:CI traded down $0.55 during trading hours on Friday, hitting $338.71. The company's stock had a trading volume of 2,010,294 shares, compared to its average volume of 1,580,930. The Cigna Group has a 52-week low of $240.50 and a 52-week high of $365.71. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.75. The stock has a market capitalization of $96.22 billion, a P/E ratio of 27.81, a price-to-earnings-growth ratio of 1.03 and a beta of 0.57. The stock has a fifty day moving average of $352.19 and a 200-day moving average of $322.48.

The Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The business had revenue of $57.25 billion during the quarter, compared to analysts' expectations of $56.59 billion. During the same quarter in the prior year, the business posted $5.41 EPS. The company's revenue for the quarter was up 23.2% on a year-over-year basis. On average, equities analysts forecast that The Cigna Group will post 28.47 earnings per share for the current year.

The Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be issued a $1.40 dividend. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.65%. The Cigna Group's payout ratio is 45.98%.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI - Free Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Should you invest $1,000 in The Cigna Group right now?

Before you consider The Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.

While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

Search Headlines: